Author

Daniel J. Sikkema

Observed names: Daniel Sikkema, Sikkema, Daniel J.

Observed institutions: Merck & Co., Inc., Rahway, NJ, USA (United States), Centers for Disease Control and Prevention, United States Food and Drug Administration, LabCorp (United States), University of Alabama at Birmingham, Buffalo VA Medical Center, GlaxoSmithKline (United States), University at Buffalo, State University of New York, Michigan State University

OpenAlex ID: A5110036423

Enzyme-Linked Immunosorbent Assay for Quantitation of Human Antibodies to Pneumococcal Polysaccharides

2003 · Catherine M. Wernette, Carl E. Frasch, et al. · Clinical and Vaccine Immunology · 336

Optimization and Validation of a Multiplex, Electrochemiluminescence-Based Detection Assay for the Quantitation of Immunoglobulin G Serotype-Specific Antipneumococcal Antibodies in Human Serum

2009 · Rocio D. Marchese, Derek Puchalski, et al. · Clinical and Vaccine Immunology · 98

Outer membrane peptides ofYersinia pestis mediating siderophore-independent assimilation of iron

1989 · Daniel J. Sikkema, Robert R. Brubaker · BioMetals · 49

False-positive immunogenicity responses are caused by CD20+ B cell membrane fragments in an anti-ofatumumab antibody bridging assay

2013 · Keguan Chen, Jerry G. Page, et al. · Journal of Immunological Methods · 33

Enzyme-Linked Immunosorbent Assay for Measuring Antibodies to Pneumococcal Polysaccharides for the PNEUMOVAX 23 Vaccine: Assay Operating Characteristics and Correlation to the WHO International Assay

2006 · Rocio D. Marchese, Neil T. Jain, et al. · Clinical and Vaccine Immunology · 33

Relationship between Serum Bactericidal Activity and Serogroup-Specific Immunoglobulin G Concentration for Adults, Toddlers, and Infants Immunized withNeisseria meningitidisSerogroup C Vaccines

2000 · Daniel J. Sikkema, Keith E. Friedman, et al. · Clinical and Diagnostic Laboratory Immunology · 30

Development of an enzymatic assay for the detection of neutralizing antibodies against therapeutic angiotensin-converting enzyme 2 (ACE2)

2013 · Karen Liao, Daniel Sikkema, et al. · Journal of Immunological Methods · 23

11th GCC Closed Forum: Cumulative Stability; Matrix Stability; Immunogenicity assays; Laboratory Manuals; Biosimilars; Chiral methods; Hybrid LBA/LCMS Assays; Fit-for-Purpose Validation; China Food and Drug Administration Bioanalytical Method Validation

2018 · Rafiq Islam, Chad Briscoe, et al. · Bioanalysis · 16

PDF

Inhibition of interleukin-5 induced false positive anti-drug antibody responses against mepolizumab through the use of a competitive blocking antibody

2016 · Karen Liao, Erik Meyer, et al. · Journal of Immunological Methods · 14

PDF

Isolation and characterization of the Haemophilus influenzae tolQ, tolR, tolA and tolB genes

1996 · Keya Sen, Daniel J. Sikkema, et al. · Gene · 14

Complexities of Clinical Assay Development and Optimization Prior to First-in-Man Immunization Trials – A Description of Immunogenicity Assay Development for the Testing of Samples from a Phase 1 Alzheimer's Vaccine Trial

2008 · Olivia Hammond, James Reynolds, et al. · Journal of Immunoassay and Immunochemistry · 10

Assignment of Weight-Based Immunoglobulin G1 (IgG1) and IgG2 Units in Antipneumococcal Reference Serum Lot 89-S(F) for Pneumococcal Polysaccharide Serotypes 1, 4, 5, 7F, 9V, and 18C

2005 · Daniel J. Sikkema, Nancy A. Ziembiec, et al. · Clinical and Vaccine Immunology · 6

Effect of Antigen Coating Conditions on Enzyme-Linked Immunosorbent Assay for Detection of Immunoglobulin G Antibody to Neisseria meningitidis Serogroup Y and W135 Capsular Polysaccharide Antigens in Serum

2003 · Peter C. Giardina, Renee E. Evans, et al. · Clinical and Vaccine Immunology · 6

Recommendations on biomarker assay validation (BAV) in tissues by GCC

2025 · Moucun Yuan, Aihua Liu, et al. · Bioanalysis · 4

PDF

Development of a Multiplexed HPV L1 Virus‐Like Particle Type‐Specific Immunoglobulin Subclass and Isotyping Assay

2008 · David William Opalka, Katie Marie Matys, et al. · The FASEB Journal · 3

Outer membrane protein P6 of Haemophilus influenzae binds to its own gene

1992 · Daniel J. Sikkema, M. Bud Nelson, et al. · Molecular Microbiology · 3

17th GCC Closed Forum: Integrative Bioanalysis, Patient-centric Sampling, Emerging Technologies, Data Integrity, Sample Reconciliation, Discrepancies of ELISpot Data, Cross-validation Harmonization, Ultrasensitive Platforms for ADA Assays, Remote Regulatory Assessments, Shedding Assays by PCR, and Biomarker Tissue Assays

2025 · Jennifer Zimmer, Mark O’dell, et al. · Bioanalysis · 2

PDF

Enzyme-Linked Immunosorbent Assay for Measuring Antibodies to Pneumococcal Polysaccharides for the PNEUMOVAX 23 Vaccine: Assay Operating Characteristics and Correlation to the WHO International Assay

2008 · Rocio D. Marchese, Neil T. Jain, et al. · Clinical and Vaccine Immunology · 1

18 th GCC Closed Forum: Compliance with FDA Biomarkers Guidance, Novel ELN/LIMS Platforms, Sample Reconciliation, Emerging Technologies, Improvements in ELISpot, Post-extraction Sample Stability, LBA Singlicate, Regulatory Inspections, Chicken anti-Human IgG, Cross-validation Harmonization

2026 · Shane Karnik, Jennifer Zimmer, et al. · Bioanalysis

PDF

P4‐380: The challenges to the development of a safety biomarker assay to detect amyloid‐β‐specific T cell activation

2008 · Holly A. Lash, Jennifer E. Talaty, et al. · Alzheimer s & Dementia

Characterization of the Antibody Response to Two Distinct Neutralizing Epitopes on Human Papilloma virus Type 6 Virus‐Like Particle

2008 · Katie Matys, David Opalka, et al. · The FASEB Journal

Works count: 29

Citation count: 681

H-index: 10

I10-index: 11